Skip to content
Recall Observatory FDA recall evidence

Drug product

Ceftriaxone for Injection USP, 250 mg, packaged in a) one Single Use Vial (NDC 68180-611-01) and b) 10 Single Use Vials per box (NDC 68180-611-10); Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., 111 South Calvert Street, Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Mandideep 462 046 INDIA.

D-0355-2019

December 20, 2018

Class I

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 81796
Status
Terminated
Classification
Class I
Quantity
a) 12,000 vials; b) 11,763 boxes
Official record key
drug-enforcement:D-0355-2019

Official wording

Reason: Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Code information: Lot #: a) C600142, Exp 08/19; b) C600136, Exp 08/19; C600182, Exp 09/19, C700147, Exp 05/20; C700207, Exp 09/20 Additional lots added 12/19/2018 - C600142, C700147 and C700207

Distribution pattern: Nationwide in the USA and Puerto Rico.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate Matter